Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globant S.A. stock logo
GLOB
Globant
$83.76
-1.7%
$98.55
$82.39
$238.32
$3.69B1.2745,865 shs363,016 shs
Hinge Health Inc. stock logo
HNGE
Hinge Health
$47.50
+2.2%
$0.00
$33.42
$52.16
$3.71BN/A986,369 shs223,707 shs
Ibotta, Inc. stock logo
IBTA
Ibotta
$36.88
-0.2%
$44.01
$31.40
$79.80
$933.43M-1.29411,719 shs152,793 shs
Remitly Global, Inc. stock logo
RELY
Remitly Global
$16.95
-1.4%
$20.39
$12.43
$27.32
$3.46B0.132.23 million shs1.53 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globant S.A. stock logo
GLOB
Globant
+0.80%-2.71%-8.07%-19.37%-56.59%
Hinge Health Inc. stock logo
HNGE
Hinge Health
-0.64%+5.28%+24.09%+4,661,999,900.00%+4,661,999,900.00%
Ibotta, Inc. stock logo
IBTA
Ibotta
+0.19%-0.75%-5.25%-22.27%-47.48%
Remitly Global, Inc. stock logo
RELY
Remitly Global
-1.55%-5.97%-16.76%-13.80%+27.07%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Globant S.A. stock logo
GLOB
Globant
4.8756 of 5 stars
4.32.00.03.62.71.73.1
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/AN/AN/AN/AN/AN/A
Ibotta, Inc. stock logo
IBTA
Ibotta
2.9275 of 5 stars
4.41.00.00.01.11.71.3
Remitly Global, Inc. stock logo
RELY
Remitly Global
2.2165 of 5 stars
3.41.00.00.02.12.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globant S.A. stock logo
GLOB
Globant
2.56
Moderate Buy$167.2599.68% Upside
Hinge Health Inc. stock logo
HNGE
Hinge Health
3.06
Buy$49.363.91% Upside
Ibotta, Inc. stock logo
IBTA
Ibotta
2.83
Moderate Buy$61.6067.03% Upside
Remitly Global, Inc. stock logo
RELY
Remitly Global
2.89
Moderate Buy$28.8870.40% Upside

Current Analyst Ratings Breakdown

Latest IBTA, GLOB, RELY, and HNGE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2025
Globant S.A. stock logo
GLOB
Globant
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$87.00
7/14/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
7/14/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Outperform$58.00
7/14/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Citizens Jmp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageStrong-Buy$58.00
7/14/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$45.00 ➝ $60.00
7/14/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$43.00 ➝ $51.00
6/26/2025
Globant S.A. stock logo
GLOB
Globant
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$165.00 ➝ $97.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$48.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$48.00
6/16/2025
Hinge Health Inc. stock logo
HNGE
Hinge Health
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$45.00
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globant S.A. stock logo
GLOB
Globant
$2.42B1.53$8.80 per share9.52$47.19 per share1.77
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/AN/AN/AN/A
Ibotta, Inc. stock logo
IBTA
Ibotta
$367.25M2.54$2.51 per share14.67$14.77 per share2.50
Remitly Global, Inc. stock logo
RELY
Remitly Global
$1.26B2.73N/AN/A$3.36 per share5.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globant S.A. stock logo
GLOB
Globant
$165.73M$3.3824.7911.672.616.16%11.08%7.38%8/13/2025 (Estimated)
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/A0.00N/AN/AN/AN/A8/5/2025 (Confirmed)
Ibotta, Inc. stock logo
IBTA
Ibotta
$68.74M$1.4824.923.0816.24%15.04%9.71%8/13/2025 (Confirmed)
Remitly Global, Inc. stock logo
RELY
Remitly Global
-$36.98M-$0.03N/A112.97N/A-0.34%-0.70%-0.45%7/21/2025 (Estimated)

Latest IBTA, GLOB, RELY, and HNGE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Globant S.A. stock logo
GLOB
Globant
$1.52N/AN/AN/A$612.66 millionN/A
5/15/2025Q1 2025
Globant S.A. stock logo
GLOB
Globant
$1.58$1.50-$0.08$0.68$622.18 million$611.09 million
5/14/2025Q1 2025
Ibotta, Inc. stock logo
IBTA
Ibotta
$0.01$0.02+$0.01$0.02$81.70 million$84.57 million
5/7/2025Q1 2025
Remitly Global, Inc. stock logo
RELY
Remitly Global
-$0.04$0.05+$0.09$0.05$347.81 million$361.62 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Globant S.A. stock logo
GLOB
Globant
N/AN/AN/AN/AN/A
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/AN/AN/A
Ibotta, Inc. stock logo
IBTA
Ibotta
N/AN/AN/AN/AN/A
Remitly Global, Inc. stock logo
RELY
Remitly Global
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globant S.A. stock logo
GLOB
Globant
0.13
1.56
1.56
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/A
Ibotta, Inc. stock logo
IBTA
Ibotta
N/A
2.69
2.69
Remitly Global, Inc. stock logo
RELY
Remitly Global
N/A
2.78
2.78

Institutional Ownership

CompanyInstitutional Ownership
Globant S.A. stock logo
GLOB
Globant
91.60%
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/A
Ibotta, Inc. stock logo
IBTA
Ibotta
N/A
Remitly Global, Inc. stock logo
RELY
Remitly Global
74.25%

Insider Ownership

CompanyInsider Ownership
Globant S.A. stock logo
GLOB
Globant
2.67%
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/A
Ibotta, Inc. stock logo
IBTA
Ibotta
16.08%
Remitly Global, Inc. stock logo
RELY
Remitly Global
7.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Globant S.A. stock logo
GLOB
Globant
31,28044.03 million42.85 millionOptionable
Hinge Health Inc. stock logo
HNGE
Hinge Health
1,51478.02 millionN/AN/A
Ibotta, Inc. stock logo
IBTA
Ibotta
N/A25.31 million21.24 millionN/A
Remitly Global, Inc. stock logo
RELY
Remitly Global
2,800203.86 million188.57 millionOptionable

Recent News About These Companies

RELY Remitly Global, Inc. - Seeking Alpha
Remitly Global, Inc. (RELY): A Bull Case Theory

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Globant stock logo

Globant NYSE:GLOB

$83.76 -1.41 (-1.66%)
As of 01:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Globant S.A., together with its subsidiaries, provides technology services worldwide. It provides digital solutions comprising blockchain, cloud technologies, cybersecurity, data and artificial intelligence, digital experience and performance, code, Internet of Things, metaverse, and engineering and testing; and enterprise technology solutions and services, such as Agile organization, Cultural Hacking, process optimization services, as well as AWS, Google Cloud, Microsoft, Oracle, SalesForce, SAP, and ServiceNow technology solutions. Further, the company provides e-commerce, conversational interfaces, design, digital marketing, and digital product delivery services. Additionally, it operates Augoor, an AI-powered platform; MagnifAI, an AI-powered solution for software quality assurance; StarMeUp, a science-based AI platform; WaaSabi, a finance platform; Walmeric, a lead-to-revenue management platform; GeneXus, a suit of AI development tools; Navigate for process optimization powerhouse; BeHealthy, a white-label platform; and FluentLab, an AI conversational and engagement solution. The company offers its services to various industries, including media and entertainment, professional services, technology and telecommunications, travel and hospitality, banks, financial services and insurance, consumer, retail and manufacturing, health care, and others. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.

Hinge Health stock logo

Hinge Health NYSE:HNGE

$47.50 +1.00 (+2.15%)
As of 01:10 PM Eastern

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients. We have designed our platform to address a broad spectrum of MSK care—from acute injury, to chronic pain, to post-surgical rehabilitation. Members receive personalized and largely automated MSK care through our AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device, all designed and monitored by our AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Our platform can improve pain and function and reduce the need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere and embrace movement as a way of life. There is no shortage of new technologies in the healthcare industry, yet the cost of care continues to rise. In other industries, the launch of new technologies has generally improved end-user experiences and lowered costs. In healthcare, however, new technologies have not always been successful in lowering the cost of care or improving clinical outcomes. We believe there are two key reasons for healthcare’s idiosyncratic response to technology: • Automating most aspects of care is difficult because so many healthcare interventions involve unstructured physical tasks. • The current framework for healthcare reimbursement has specific pathways to pay for care, which means new technologies are constrained to deliver within this framework. At Hinge Health, we have taken these challenges head-on. To address the automation of care, we have weaved together AI-enabled capabilities - such as our AI-powered motion tracking technology, TrueMotion, our proprietary FDA-cleared wearable device, Enso, and our AI-supported care team - to deliver scalable and personalized MSK care. According to our estimates based on data from 2024, our platform reduced the number of human care team hours associated with traditional physical therapy by approximately 95%. We have done this while improving our high member satisfaction over time. To address healthcare reimbursement constraints, we developed novel billing methods for our innovative technology by both directly selling to employers while also partnering with health plans, pharmacy benefit managers (“PBMs”), third-party administrators (“TPAs”), and other ecosystem entities to efficiently provide our platform to clients and members. While the MSK market is massive, existing solutions have fallen short as they are often expensive, ineffective, inconvenient to access, and delivered in a one-to-one or few-to-one care setting. Effective MSK care should be engaging, easy to use, and accessible anytime, anywhere. We developed Hinge Health to be simple and accessible, complete, personalized, and scalable. • Simple and accessible: We provide members access to our platform at no direct cost to them and without a copay or deductible. Members can access our broad spectrum of MSK care through a single on-demand app, designed to provide an engaging, seamless, and convenient digital experience whenever and wherever the member chooses. Potential members can complete a simple intake form, download the app, and start exercises soon thereafter. During the year ended December 31, 2024, approximately 64% of members were onboarded on the same day they completed their intake form, and approximately 75% of members were onboarded within the first week. • Complete: Our platform offers a wide range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. We also offer non-addictive and non-invasive pain relief via electrostimulation through our proprietary FDA-cleared wearable device, Enso, that is seamlessly integrated into our platform. • Personalized: Our platform delivers smarter care through AI and machine learning. Our AI model is trained on a large, proprietary MSK data set, and our technology is continuously learning and improving as each new member enrolls and engages with our programs, which creates a positive feedback loop. As of March 31, 2025, we had treated over one million members and our programs had tracked over 74 million activity sessions and 32 million member-reported outcome logs. We focus on personalization to keep members moving: from customized care plans to real-time in-app exercise feedback based on the member’s input and our proprietary motion tracking technology. • Scalable: Our AI-powered motion tracking technology, TrueMotion, allows us to deliver scalable and largely automated care. According to our estimates based on data from 2024, our platform reduced the number of human care team hours associated with traditional physical therapy by approximately 95%. While most of our programs provide members with access to a dedicated care team, our technology automates most aspects of care delivery while allowing our members to progress through their exercise therapy sessions on their own time. We have developed an efficient go-to-market model by working directly with our partners and clients. We seek to be the best solution on the market, the most validated solution on the market, and the easiest to buy. Our clients are primarily self-insured employers and include many of the nation’s leading enterprises across a broad range of industries and sizes. Within this segment, we also serve many public sector self-insured employers, such as state and local city governments and labor unions. In most instances, we partner with clients’ health plans, TPAs, PBMs, or other ecosystem entities to reduce the friction of contracting, procurement, security and IT reviews, onboarding, and billing. We are also in the early stages of expanding to serve health plans’ fully-insured and Medicare Advantage populations and federal insurance plans. As of December 31, 2024, we had approximately 20 million contracted lives across more than 2,250 clients. We had active client agreements with 49% of the Fortune 100 companies and 42% of the Fortune 500 companies, as of December 31, 2024. Despite this progress, our current contracted lives only represent 5% of our total addressable market. We believe that we grow efficiently because of our scalable, repeatable go-to-market model. We sell through our direct sales force and our partners. Once we contract with a client, we are most often the sole digital MSK care provider offered to their contracted lives. Our average contract term is three years. For the term of each contract, we are able to enroll, engage, and re-engage the client’s eligible lives, driving a recurring, repeatable revenue model, which is demonstrated in our net dollar retention of 117% as of December 31, 2024. Our 12-month client retention rate was 98% as of December 31, 2024. Additionally, we have a high level of client satisfaction, as shown by our client net promoter score (“NPS”) of 87 as of October 31, 2024. We also invested early in building our partner network. As of March 31, 2025, we had over 50 partners. Our partners include the five largest national health plans by self-insured lives, and the top three PBMs by market share. As of that date, we had retained 100% of our partners that we chose to work with since inception, excluding partners who were acquired. We have experienced significant growth since our inception, with a recurring revenue business model. As of December 31, 2024, we had over 532,000 members and more than 2,250 clients, compared to approximately 371,000 members and approximately 1,650 clients as of December 31, 2023. Our principal executive offices are located in San Francisco, California.

Ibotta stock logo

Ibotta NYSE:IBTA

$36.88 -0.08 (-0.22%)
As of 01:11 PM Eastern

Ibotta’s mission is to Make Every Purchase Rewarding. Our technology allows CPG brands to deliver digital promotions to over 200 million consumers through a single, convenient network called the Ibotta Performance Network (IPN). We are pioneers in success-based marketing: we only get paid when our client’s promotion results in a sale, not when a consumer merely views or clicks on the promotion. We have built the largest digital item-level promotions network in the United States by forming strategic relationships with major retailers such as Walmart Inc. (Walmart) and Dollar General Corporation (Dollar General), which use our digital offers to power their loyalty programs on a white-label basis. Through the IPN, our clients can also reach millions more consumers on our widely used rewards app digital properties, which include the Ibotta-branded cash back mobile app, website, and browser extension (collectively, Ibotta D2C). We work directly with over 850 different clients, representing over 2,400 different CPG brands to source exclusive offers as of December 31, 2023. Most of our offers cover products in non-discretionary categories, such as grocery, but we also work with general merchandise manufacturers in categories such as toys, clothing, beauty, electronics, pet, home goods, and sporting goods. Over time, our clients have generally ramped up their spend with us, and they rarely drop off our network. In fact, of our top 100 clients, 96% were retained from 2022 to 2023. Our technology platform uses an Artificial Intelligence (AI)-enabled offer engine that is designed to match and distribute the right offer to the right consumer at the right time. This is possible because we receive a large volume of item-level purchase data through our secure point of sale (POS) integrations with 85 different retailers as of December 31, 2023. Using this data, we form a profile of each consumer based on what they have bought in the past and how they have responded to various price promotions. From there, we build recommenders that are driven by machine learning and designed to create personalized savings experiences for each consumer. The more data we accumulate, the smarter our recommenders become. Whatever our clients’ specific objectives may be – such as encouraging brand switching, shortening purchase cycles, incentivizing consumers to stock up, or promoting around key seasonal events – our platform helps them design a promotional campaign to accomplish their goals. Ibotta’s technology tracks which offers are selected by consumers, matches offers to the products that have been purchased, logs redemptions, handles the flow of funds, and takes care of all downstream billing and logistics. We perform the function of “air traffic control,” meaning our network enables offers to be matched, distributed, and redeemed across multiple large third-party publishers in a coordinated fashion. This minimizes the risks that offer budgets are exceeded and that consumers redeem the same offer several times for a single purchase (i.e., offer stacking). Our client tools allow CPG brands to set up campaigns, monitor redemption and budget levels, and analyze overall campaign performance – all in a single, convenient interface. We deliver success-based digital promotions at-scale because we manage a growing, open network of third-party publishers that host our offers. Retailers are among our most important publishers because their apps and websites are frequently visited by consumers with high purchase intent. A retailer may ingest digital offers from Ibotta’s Application Programming Interface (API) and present them to its consumers as part of its own branded loyalty program. We call these partners “retailer publishers.” We believe retailer publishers choose to work with Ibotta because we are a trusted partner that can provide a large universe of exclusive offers coupled with a set of plug and play capabilities that would be difficult for them to create and scale on their own. For example, Ibotta and Walmart entered into a multi-year strategic relationship that makes Ibotta the exclusive provider of digital item-level rebate offer content for Walmart U.S., across all product categories, for online and offline shopping. Consumers redeem our offers on Walmart properties without ever creating an Ibotta account. Instead, they can select manufacturer offers from the Walmart website or app, buy the featured items in-store or online, and instantly earn Walmart Cash which can be applied to future purchases in a Walmart store or on Walmart.com. All CPG brands wishing to run digital item-level rebates on Walmart’s website can only do so through the IPN. Ibotta also partners with several other leading retailer publishers. For example, Ibotta partners with Family Dollar, a subsidiary of Dollar Tree, Inc. We also work indirectly to publish offers on certain retailer properties, including Kroger (powering Kroger Cash) and Shell (powering Shell Fuel Rewards). In addition to providing digital offers for retailers, Ibotta also makes the same offers available on its own digital properties, which include Ibotta D2C. Since 2012, over 50 million Americans have registered for our free app. Ibotta D2C reaches a highly engaged audience of savings-conscious consumers who want a single digital starting point where they can find cash back offers across a variety of retailers. Many of these consumers decide where to shop based on the availability of deals in different retailers. Once the IPN launched, Ibotta D2C became a publisher on the IPN, meaning it is now one of many nodes through which our digital offers are delivered to the end consumer. In the future, we believe the IPN may be extended to other publishers across a variety of new verticals. For example, new publishers could include delivery services, banks, or other apps and websites that want to give their consumers access to offers on popular everyday items without having to source those offers from thousands of different CPG brands or secure item-level data from multiple integrated retailers where the offers can be redeemed. We believe Ibotta is well positioned to capitalize on a large and growing market opportunity. U.S. consumers spent approximately $1.2 trillion dollars in the grocery sector in 2023. CPG brands compete fiercely to influence consumer spending habits, spending approximately $200 billion on marketing annually in the United States. In fact, no other industry spends more on marketing, as a percentage of overall budgets, than CPG. Most of our revenue is redemption revenue which is generated from redemptions of offers across the IPN. A significant portion of that redemption revenue arises from offer redemptions on third-party publishers. We also generate revenue by selling ad products on our Ibotta D2C properties. Specifically, we allow CPG brands and retailers to enhance awareness of their offers by buying display ads, in-app videos, or email marketing campaigns. We also charge partners a licensing fee to leverage our aggregated data in ways that help them better understand their target consumers and improve their promotional activities. Finally, on Ibotta’s D2C properties, we also allow thousands of online retailers to advertise and present consumers with their own sitewide cash back offers. These clients benefit from the incremental sales generated by Ibotta’s savings-conscious audience. Our revenue growth significantly accelerated with the addition of new publishers to the IPN. Most recently, the rollout of our offers on the digital property of Walmart has attracted larger audiences, and in turn, resulted in greater spend by CPG brands and a greater number of redeemed offers. These developments have increased our scale, growth and profitability. • Total revenue grew from $210.7 million in 2022 to $320.0 million in 2023, an increase of 52%; • Redemption revenue grew from $138.7 million (or 66% of total revenue) in 2022 to $243.9 million (or 76% of total revenue) in 2023, an increase of 76%; • Gross profit grew from $164.5 million in 2022 to $276.0 million in 2023, an increase of 68%; • Net income (loss) improved from $(54.9) million in 2022 to $38.1 million in 2023; • Net income (loss) as a percent of revenue improved from (26)% in 2022 to 12% in 2023; and • Adjusted EBITDA margin improved from (13)% in 2022 to 26% in 2023. We were incorporated in 2011 as Zing Enterprises, Inc., a Delaware corporation. In 2012, we changed our name to Ibotta, Inc. Our principal executive office is located at 1801 California Street, Suite 400, Denver, Colorado.

Remitly Global stock logo

Remitly Global NASDAQ:RELY

$16.94 -0.24 (-1.37%)
As of 01:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Remitly Global, Inc. provides digital financial services for immigrants and their families. It primarily offers cross-border remittance services in approximately 170 countries. The company was incorporated in 2011 and is headquartered in Seattle, Washington.